Tenon Medical Receives Nasdaq Delisting Notice for Equity Non-Compliance
Tenon Medical, Inc. received a notice from Nasdaq on May 21, 2026, stating non-compliance with the minimum stockholders' equity requirement for continued listing. The company reported stockholders' equity of $1,895,000 as of March 31, 2026, which is below Nasdaq's required $2,500,000. Tenon Medical has until July 6, 2026, to submit a plan to regain compliance, with a potential extension of up to 180 days if the plan is accepted. The notice does not immediately affect the company's stock listing or trading.
Key Highlights
- Tenon Medical received a Nasdaq notice for non-compliance with the minimum stockholders' equity requirement.
- Nasdaq Listing Rule 5550(b)(1) requires listed companies to maintain $2,500,000 in stockholders' equity.
- Company reported stockholders' equity of $1,895,000 as of March 31, 2026, below the minimum.
- Tenon Medical does not meet alternative compliance standards for market value or net income.
- The company has 45 calendar days, until July 6, 2026, to submit a plan to regain compliance.
- If the plan is accepted, Nasdaq may grant an extension of up to 180 calendar days.
- The notice has no immediate effect on the listing or trading of the company's common stock.
Price Impact
More from TNON
Tenon Medical Increases Executive Salaries, Bonuses; Extends Ferrari's Term
Tenon Medical Amends Bylaws, Changes Stockholder Meeting Quorum
Tenon Medical Q1 Net Loss Narrows to $3.48M; Going Concern Doubt